| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.63▲ | 1.63▲ | 1.63▲ | 1.55▲ | 1.42▲ |
| MA10 | 1.62▲ | 1.63▲ | 1.60▲ | 1.45▲ | 1.22▲ |
| MA20 | 1.63▲ | 1.58▲ | 1.56▲ | 1.31▲ | 1.26▲ |
| MA50 | 1.58▲ | 1.48▲ | 1.45▲ | 1.15▲ | 1.28▲ |
| MA100 | 1.49▲ | 1.38▲ | 1.31▲ | 1.25▲ | 1.17▲ |
| MA200 | 1.39▲ | 1.22▲ | 1.16▲ | 1.35▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.000▼ | 0.003▲ | 0.031▲ | 0.052▲ |
| RSI | 60.077▲ | 62.640▲ | 63.463▲ | 70.733▲ | 59.698▲ |
| STOCH | 38.194 | 68.515 | 82.073▲ | 80.820▲ | 83.136▲ |
| WILL %R | -55.556 | -17.857▲ | -11.364▲ | -4.854▲ | -2.646▲ |
| CCI | 40.230 | 65.725 | 82.232 | 157.404▲ | 176.294▲ |
|
Wednesday, June 25, 2025 02:39 PM
Phase 3 NEAT enrollment momentum continues with 99 total participants enrolled to date Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power ...
|
|
Wednesday, June 25, 2025 09:05 AM
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX) (“Quince” or the “Company”), a late-stage biotechnology company dedicated to unlocking the power of a ...
|
|
Wednesday, June 25, 2025 06:05 AM
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced its ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/06/25 | 1.58 | 1.665 | 1.555 | 1.64 | 398,930 |
| 27/06/25 | 1.51 | 1.55 | 1.43 | 1.55 | 140,255 |
| 26/06/25 | 1.59 | 1.5988 | 1.4701 | 1.50 | 208,161 |
| 25/06/25 | 1.44 | 1.6199 | 1.42 | 1.60 | 435,060 |
| 24/06/25 | 1.31 | 1.49 | 1.30 | 1.45 | 307,721 |
| 23/06/25 | 1.30 | 1.33 | 1.29 | 1.32 | 137,291 |
| 20/06/25 | 1.41 | 1.43 | 1.30 | 1.30 | 376,055 |
| 18/06/25 | 1.34 | 1.40 | 1.33 | 1.36 | 802,747 |
| 17/06/25 | 1.37 | 1.3799 | 1.29 | 1.36 | 72,420 |
| 16/06/25 | 1.44 | 1.445 | 1.337 | 1.38 | 214,717 |
|
|
||||
|
|
||||
|
|